INTRAGENIC REARRANGEMENT BURDEN AS A GENOMIC PREDICTOR OF IMMUNOTHERAPY BENEFIT IN TRIPLE-NEGATIVE BREAST CANCER
$846,182FY2024Defense Health AgencyDOD
University Of Pittsburgh - Of The Commonwealth System Of Higher Education
University Of Pittsburgh - Of The Commonwealth System Of Higher Education